| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 13,599 | 12,619 | 13,375 | 13,061 | | Cost of Revenue | 4,582 | 4,120 | 4,429 | 3,929 | | | Gross Profit | 9,017 | 8,499 | 8,946 | 9,132 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,718 | 6,572 | 6,735 | 7,146 | | Non Recurring | 1,232 | 11,136 | 65 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,067 | (9,209) | 2,146 | 1,986 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27 | 466 | 68 | 78 | | Earnings Before Interest And Taxes | 2,094 | (8,743) | 2,214 | 2,064 | | Interest Expense | 76 | 30 | 59 | 56 | | Income Before Tax | 2,018 | (8,773) | 2,155 | 2,008 | | Income Tax Expense | 827 | 80 | 860 | 829 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,191 | (8,853) | 1,295 | 1,179 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,191 | (8,853) | 1,295 | 1,179 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,191 | ($8,853) | $1,295 | $1,179 |
|
0.33% Nasdaq 0.00%
Income Statement
